Aidan King is the Co-Founder and Managing Partner of Fountain Healthcare Partners. See sector focus and contact routes.
Aidan King is the Co-Founder and Managing Partner of Fountain Healthcare Partners, a transatlantic life science venture capital firm he established in 2008 after serving as a founding member of Elan Corporation’s corporate venture group. His investment thesis targets seed and early-stage companies in specialty pharmaceuticals, biotechnology, medical devices, and diagnostics across Europe and the United States. King holds a CFA charter and previously executed twenty-two strategic investments in pharma and biotech while at Elan, though specific typical check sizes and lead-versus-follow behavior for his current firm are not publicly detailed. Notable portfolio companies include Chrono Therapeutics, Velicept Therapeutics, and Syndesi Therapeutics, for which he currently serves on the board, as well as Ermium Therapeutics, where he joined the board in June 2022. He also previously represented the firm on the boards of acquired companies Civitas Therapeutics and Palyon Medical. While King’s background as a qualified pharmacist from Trinity College Dublin and his MBA from University College Dublin inform his sector expertise, no distinctive public writing
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Aidan King · Full investor directory · Investor access · Company funding database